1
|
Carrillo-López N, Panizo S, Martín-Carro B, Mayo Barrallo JC, Román-García P, García-Castro R, Fernández-Gómez JM, Hevia-Suárez MÁ, Martín-Vírgala J, Fernández-Villabrille S, Martínez-Arias L, Vázquez SB, Calleros Basilio L, Naves-Díaz M, Cannata-Andía JB, Quirós-González I, Alonso-Montes C, Fernández-Martín JL. Redox Metabolism and Vascular Calcification in Chronic Kidney Disease. Biomolecules 2023; 13:1419. [PMID: 37759819 PMCID: PMC10526886 DOI: 10.3390/biom13091419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2023] [Revised: 09/07/2023] [Accepted: 09/12/2023] [Indexed: 09/29/2023] Open
Abstract
Vascular calcification (VC) is a common complication in patients with chronic kidney disease which increases their mortality. Although oxidative stress is involved in the onset and progression of this disorder, the specific role of some of the main redox regulators, such as catalase, the main scavenger of H2O2, remains unclear. In the present study, epigastric arteries of kidney transplant recipients, a rat model of VC, and an in vitro model of VC exhibiting catalase (Cts) overexpression were analysed. Pericalcified areas of human epigastric arteries had increased levels of catalase and cytoplasmic, rather than nuclear runt-related transcription factor 2 (RUNX2). In the rat model, advanced aortic VC concurred with lower levels of the H2O2-scavenger glutathione peroxidase 3 compared to controls. In an early model of calcification using vascular smooth muscle cells (VSMCs), Cts VSMCs showed the expected increase in total levels of RUNX2. However, Cts VMSCs also exhibited a lower percentage of the nucleus stained for RUNX2 in response to calcifying media. In this early model of VC, we did not observe a dysregulation of the mitochondrial redox state; instead, an increase in the general redox state was observed in the cytoplasm. These results highlight the complex role of antioxidant enzymes as catalase by regulation of RUNX2 subcellular location delaying the onset of VC.
Collapse
Affiliation(s)
- Natalia Carrillo-López
- Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, 33011 Oviedo, Spain; (N.C.-L.); (S.P.); (B.M.-C.); (P.R.-G.); (J.M.-V.); (S.F.-V.); (L.M.-A.); (S.B.V.); (M.N.-D.); (C.A.-M.); (J.L.F.-M.)
- Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28029 Madrid, Spain;
| | - Sara Panizo
- Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, 33011 Oviedo, Spain; (N.C.-L.); (S.P.); (B.M.-C.); (P.R.-G.); (J.M.-V.); (S.F.-V.); (L.M.-A.); (S.B.V.); (M.N.-D.); (C.A.-M.); (J.L.F.-M.)
- Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28029 Madrid, Spain;
| | - Beatriz Martín-Carro
- Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, 33011 Oviedo, Spain; (N.C.-L.); (S.P.); (B.M.-C.); (P.R.-G.); (J.M.-V.); (S.F.-V.); (L.M.-A.); (S.B.V.); (M.N.-D.); (C.A.-M.); (J.L.F.-M.)
- Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28029 Madrid, Spain;
| | - Juan Carlos Mayo Barrallo
- Department of Cellular Morphology and Biology, Instituto Universitario de Oncologia del Principado de Asturias (IUOPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Universidad Oviedo, 33006 Oviedo, Spain;
| | - Pablo Román-García
- Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, 33011 Oviedo, Spain; (N.C.-L.); (S.P.); (B.M.-C.); (P.R.-G.); (J.M.-V.); (S.F.-V.); (L.M.-A.); (S.B.V.); (M.N.-D.); (C.A.-M.); (J.L.F.-M.)
| | - Raúl García-Castro
- Department of Nephrology, Hospital Juaneda Miramar, Red Asistencial Juaneda, 07011 Palma de Mallorca, Spain;
| | - Jesús María Fernández-Gómez
- UGC of Urology, Hospital Universitario Central de Asturias, Universidad de Oviedo, 33011 Oviedo, Spain; (J.M.F.-G.); (M.Á.H.-S.)
- Department of Surgery and Medical Surgical Specialities, Universidad de Oviedo, 33006 Oviedo, Spain
| | - Miguel Ángel Hevia-Suárez
- UGC of Urology, Hospital Universitario Central de Asturias, Universidad de Oviedo, 33011 Oviedo, Spain; (J.M.F.-G.); (M.Á.H.-S.)
- Department of Surgery and Medical Surgical Specialities, Universidad de Oviedo, 33006 Oviedo, Spain
| | - Julia Martín-Vírgala
- Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, 33011 Oviedo, Spain; (N.C.-L.); (S.P.); (B.M.-C.); (P.R.-G.); (J.M.-V.); (S.F.-V.); (L.M.-A.); (S.B.V.); (M.N.-D.); (C.A.-M.); (J.L.F.-M.)
- Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28029 Madrid, Spain;
| | - Sara Fernández-Villabrille
- Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, 33011 Oviedo, Spain; (N.C.-L.); (S.P.); (B.M.-C.); (P.R.-G.); (J.M.-V.); (S.F.-V.); (L.M.-A.); (S.B.V.); (M.N.-D.); (C.A.-M.); (J.L.F.-M.)
- Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28029 Madrid, Spain;
| | - Laura Martínez-Arias
- Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, 33011 Oviedo, Spain; (N.C.-L.); (S.P.); (B.M.-C.); (P.R.-G.); (J.M.-V.); (S.F.-V.); (L.M.-A.); (S.B.V.); (M.N.-D.); (C.A.-M.); (J.L.F.-M.)
- Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28029 Madrid, Spain;
| | - Sara Barrio Vázquez
- Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, 33011 Oviedo, Spain; (N.C.-L.); (S.P.); (B.M.-C.); (P.R.-G.); (J.M.-V.); (S.F.-V.); (L.M.-A.); (S.B.V.); (M.N.-D.); (C.A.-M.); (J.L.F.-M.)
| | - Laura Calleros Basilio
- Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28029 Madrid, Spain;
- Department of Systems Biology, Physiology Unit, Universidad de Alcalá, 28805 Alcalá de Henares, Spain
| | - Manuel Naves-Díaz
- Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, 33011 Oviedo, Spain; (N.C.-L.); (S.P.); (B.M.-C.); (P.R.-G.); (J.M.-V.); (S.F.-V.); (L.M.-A.); (S.B.V.); (M.N.-D.); (C.A.-M.); (J.L.F.-M.)
- Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28029 Madrid, Spain;
| | - Jorge Benito Cannata-Andía
- Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, 33011 Oviedo, Spain; (N.C.-L.); (S.P.); (B.M.-C.); (P.R.-G.); (J.M.-V.); (S.F.-V.); (L.M.-A.); (S.B.V.); (M.N.-D.); (C.A.-M.); (J.L.F.-M.)
- Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28029 Madrid, Spain;
- Department of Medicine, Universidad de Oviedo, 33011 Oviedo, Spain
| | - Isabel Quirós-González
- Department of Cellular Morphology and Biology, Instituto Universitario de Oncologia del Principado de Asturias (IUOPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Universidad Oviedo, 33006 Oviedo, Spain;
| | - Cristina Alonso-Montes
- Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, 33011 Oviedo, Spain; (N.C.-L.); (S.P.); (B.M.-C.); (P.R.-G.); (J.M.-V.); (S.F.-V.); (L.M.-A.); (S.B.V.); (M.N.-D.); (C.A.-M.); (J.L.F.-M.)
- Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28029 Madrid, Spain;
| | - José Luis Fernández-Martín
- Bone and Mineral Research Unit, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias, 33011 Oviedo, Spain; (N.C.-L.); (S.P.); (B.M.-C.); (P.R.-G.); (J.M.-V.); (S.F.-V.); (L.M.-A.); (S.B.V.); (M.N.-D.); (C.A.-M.); (J.L.F.-M.)
- Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), RICORS2040 (Kidney Disease), 28029 Madrid, Spain;
| |
Collapse
|
2
|
Quirós-González I, Román-García P, Alonso-Montes C, Barrio-Vázquez S, Carrillo-López N, Naves-Díaz M, Mora MI, Corrales FJ, López-Hernández FJ, Ruiz-Torres MP, Cannata-Andía JB, Fernández-Martín JL. Lamin A is involved in the development of vascular calcification induced by chronic kidney failure and phosphorus load. Bone 2016; 84:160-168. [PMID: 26769003 DOI: 10.1016/j.bone.2016.01.005] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/15/2015] [Revised: 11/16/2015] [Accepted: 01/04/2016] [Indexed: 12/18/2022]
Abstract
Vascular calcification remains one of the main factors associated to morbidity and mortality in both ageing and chronic kidney disease. Both hyperphosphataemia, a well-known promoter of vascular calcification, and abnormal processing defects of lamin A/C have been associated to ageing. The main aim of this study was to analyse the effect of phosphorus load in the differential expression pattern of genes and proteins, particularly of lamin A/C, which are involved in phenotypic change of the vascular smooth muscle cells to osteoblast-like cells. The in vivo study of the calcified abdominal aortas from nephrectomized rats receiving a high phosphorus diet showed among others, a repression of muscle related proteins and overexpression of lamin A/C. Similar results were observed in vitro, where primary vascular smooth muscle cells cultured in calcifying medium showed increased expression of prelamin A and lamin A and abnormalities in the nuclear morphology. Co-immunoprecipitation assays showed novel and important physical interactions between lamin A and RUNX2 during the process of calcification. In fact, the knockdown of prelamin A and lamin A inhibited the increase of Runx2, osteocalcin and osteopontin gene expression, calcium deposition, nuclear abnormalities and the RUNX2 protein translocation into the nucleus of the cell. These in vivo and in vitro results highlight the important role played by lamin A in the process of vascular calcification.
Collapse
Affiliation(s)
- Isabel Quirós-González
- Bone and Mineral Research Unit, Instituto Reina Sofía de Investigación, REDinREN del ISCIII, Hospital Universitario Central de Asturias, University of Oviedo, 33006 Oviedo, Asturias, Spain
| | - Pablo Román-García
- Bone and Mineral Research Unit, Instituto Reina Sofía de Investigación, REDinREN del ISCIII, Hospital Universitario Central de Asturias, University of Oviedo, 33006 Oviedo, Asturias, Spain
| | - Cristina Alonso-Montes
- Bone and Mineral Research Unit, Instituto Reina Sofía de Investigación, REDinREN del ISCIII, Hospital Universitario Central de Asturias, University of Oviedo, 33006 Oviedo, Asturias, Spain
| | - Sara Barrio-Vázquez
- Bone and Mineral Research Unit, Instituto Reina Sofía de Investigación, REDinREN del ISCIII, Hospital Universitario Central de Asturias, University of Oviedo, 33006 Oviedo, Asturias, Spain
| | - Natalia Carrillo-López
- Bone and Mineral Research Unit, Instituto Reina Sofía de Investigación, REDinREN del ISCIII, Hospital Universitario Central de Asturias, University of Oviedo, 33006 Oviedo, Asturias, Spain
| | - Manuel Naves-Díaz
- Bone and Mineral Research Unit, Instituto Reina Sofía de Investigación, REDinREN del ISCIII, Hospital Universitario Central de Asturias, University of Oviedo, 33006 Oviedo, Asturias, Spain
| | - María Isabel Mora
- Division of Hepatology and Gene Therapy, Proteomics, Genomics and Bioinformatics Unit, Centre for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain
| | - Fernando José Corrales
- Division of Hepatology and Gene Therapy, Proteomics, Genomics and Bioinformatics Unit, Centre for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain
| | - Francisco J López-Hernández
- Department of Renal Physiology, REDinREN del ISCIII, Faculty of Biology, University of Salamanca, 37007 Salamanca, Spain
| | - María Piedad Ruiz-Torres
- Department of Systems Biology, REDinREN del ISCIII, Faculty of Medicine, University of Alcalá, Alcalá de Henares, 28801, Madrid, Spain
| | - Jorge Benito Cannata-Andía
- Bone and Mineral Research Unit, Instituto Reina Sofía de Investigación, REDinREN del ISCIII, Hospital Universitario Central de Asturias, University of Oviedo, 33006 Oviedo, Asturias, Spain.
| | - José Luis Fernández-Martín
- Bone and Mineral Research Unit, Instituto Reina Sofía de Investigación, REDinREN del ISCIII, Hospital Universitario Central de Asturias, University of Oviedo, 33006 Oviedo, Asturias, Spain
| |
Collapse
|